Google+ Icon Facebook Icon Twitter Icon LinkedIn Icon E-Mail Icon language

New Italian Study 'Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study' published

New Italian Study 'Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study' published

Teams from the Unit of Medical Oncology, Carpi Civil Hospital, Modena; Oncology Unit, Guastalla Civil Hospital, Reggio Emilia; Oncology Unit, Parma Hospital, Parma have published a paper assessing the effectiveness of scalp cooling in daily clinical practice in three Italian oncology unit, using a PAXMAN system.

The data concluded that scalp cooling provides a reliable chance for breast cancer patients to keep their hair during taxane and/or anthracycline‑based chemotherapy, especially when epirubicin and taxanes are administered. Since 2017, scalp cooling is routinely offered to newly diagnosed breast cancer patients undergoing chemotherapy.

Read the paper for yourself here


Back to top